These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36033234)

  • 1. Risk and protective factors of relapse in patients with first-episode schizophrenia from perspectives of health professionals: a qualitative study in northeastern Thailand.
    Intharit J; Kittiwattanagul K; Chaveepojnkamjorn W; Tudpor K
    F1000Res; 2021; 10():499. PubMed ID: 36033234
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk and protective factors for relapse among individuals with schizophrenia: a qualitative study in Dar es Salaam, Tanzania.
    Sariah AE; Outwater AH; Malima KI
    BMC Psychiatry; 2014 Aug; 14():240. PubMed ID: 25168715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception of risk of relapse among patients with first episode and recurrent schizophrenia: a descriptive phenomenological study.
    Yu H; Sun YJ; Qin MN; Ren JX; Yu K; Song J; Zhou YQ; Liu L
    BMC Psychiatry; 2023 Aug; 23(1):582. PubMed ID: 37563579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.
    Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders
    Aust N Z J Psychiatry; 2005; 39(1-2):1-30. PubMed ID: 15660702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relapse in schizophrenia: an exploratory study of the joint conceptions of patients, parents and caregivers].
    Koenig M; Castillo MC; Urdapilleta I; Le Borgne P; Bouleau JH
    Encephale; 2011 Jun; 37(3):207-16. PubMed ID: 21703436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.
    Teferra S; Hanlon C; Beyero T; Jacobsson L; Shibre T
    BMC Psychiatry; 2013 Jun; 13():168. PubMed ID: 23773362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
    Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
    Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
    Üçok A; Kara İA
    Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and strategies for relapse prevention among individuals living with serious mental illness in South Africa: Qualitative inquiry from patients' and caregivers' perspectives.
    Mlay JP; Naidu T; Ramlall S; Mhlungu SS; Zondi M; Lessells R; Manuel JI; Tomita A
    PLoS One; 2024; 19(8):e0309238. PubMed ID: 39172928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
    Ameller A; Gorwood P
    Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relapse: causes and consequences].
    Thomas P
    Encephale; 2013 Sep; 39 Suppl 2():S79-82. PubMed ID: 24084426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT.
    Morrison AP; Pyle M; Byrne R; Broome M; Freeman D; Johns L; James A; Husain N; Whale R; MacLennan G; Norrie J; Hudson J; Peters S; Davies L; Bowe S; Smith J; Shiers D; Joyce E; Jones W; Hollis C; Maughan D
    Health Technol Assess; 2021 Jan; 25(4):1-124. PubMed ID: 33496261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors involved in recovery from schizophrenia: a qualitative study of Thai mental health nurses.
    Kaewprom C; Curtis J; Deane FP
    Nurs Health Sci; 2011 Sep; 13(3):323-7. PubMed ID: 21752168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregivers' experiences and perspectives of factors associated with relapse in Iranian people living with schizophrenia: A qualitative study.
    Zabihi Poursaadati M; Maarefvand M; Bolhari J; Hosseinzadeh S; Songhori N; Derakhshan L; Khubchandani J
    Int J Soc Psychiatry; 2023 Feb; 69(1):86-100. PubMed ID: 34971526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.